Clinical Significance of Heterogeneity in Response to Retreatment With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Patients With Lung Cancer Acquiring Secondary Resistance to the Drug
2016 ◽
Vol Volume 10
◽
pp. 3867-3872
◽
2007 ◽
Vol 98
(12)
◽
pp. 1817-1824
◽
2019 ◽
Vol 31
(1)
◽
pp. 1-7
◽
2009 ◽
Vol 15
(21)
◽
pp. 6630-6638
◽